Stefan J.M. Kraemer, M.D., M.B.A. Email and Phone Number
Stefan J.M. Kraemer, M.D., M.B.A. work email
- Valid
- Valid
- Valid
Stefan J.M. Kraemer, M.D., M.B.A. personal email
- Valid
Stefan J.M. Kraemer, M.D., M.B.A. phone numbers
An Interdisciplinary surgeon by training, start-up entrepreneur and experienced leader in the American and global biomedical industry, I bring broad strategic and practical expertise to innovative companies, from start-ups to large industries, transforming healthcare through new technologies to meet patients‘ and healthcare providers‘ needs. I started and grew a medical device and methods business, co-founded a successful angel investor network, and led medical due diligence for large and small M&A targets and successful acquisitions. Specific focus on innovation and strategic support, trend scouting and M&A on both sides of the negotiating table, closely working with R&D, Quality, Regulatory, Professional Education, Medical Information, HEOR and Reimbursement teams, Marketing and Sales. Skilled in the analysis of disruptive products and procedures from concept through device development to training, launch and publication strategy, for private or public companies with world-changing medical technologies at all development stages.Trilingual global citizen and have lived and worked in the U.S. and in Germany.
Creative Destruction Lab
View- Website:
- creativedestructionlab.com
- Employees:
- 699
-
Business AssociateCreative Destruction LabSummit, Nj, Us -
PrincipalMercator Ii - Kraemer Lifescience AdvisorsSummit, Nj, Us
-
Business MentorCreative Destruction Lab Oct 2023 - PresentToronto, Ontario, Ca -
Business MentorCreative Destruction Lab Oct 2022 - PresentToronto, Ontario, CaSupporting start-ups and early stage companies in the LifeSciences in the development and commercialization of science and technology for the betterment of humankind. -
Board MemberOpticyte Feb 2023 - PresentSeattle, Washington, UsThe world’s only device for monitoring intracellular oxygen saturation, designed for early shock detection to help prevent multiorgan failure, with the potential to guide rapid initiation and tailored titration of targeted management. In December 2022, Opticyte received the BREAKTHROUGH DEVICE DESIGNATION from the FDA. -
Board MemberRyan Hill Research Foundation Sep 2004 - Present -
MentorBioinnovate Ireland Jan 2022 - PresentGalway, Connacht, IeLifesciences - enabling and supporting innovation while excelling business growth -
PrincipalMercator Ii - Kraemer Lifescience Advisors Jan 2022 - Present
-
Vice President, Medical Affairs, Medical Safety & InformationBd Mar 2019 - Dec 2020Franklin Lakes, New Jersey, UsAppointed to lead Medical Affairs and Medical Safety for all BD Interventional businesses. Subsequently leading Medical Information Integration programme, focusing on development of a structured approach to MI in order to harness the value of information and data in a secure and reliable manner. Additionally, provided review and approval of MI content, supported the implementation of a new MI knowledge base and led training and supported scaled roll-out. -
Interim Vice President, Ma, PharmocovigilanceBd Apr 2018 - May 2019Franklin Lakes, New Jersey, UsAppointed to lead Medical Affairs Pharmacovigilance. From 4.2018 to 5.2019 appointed to reestablish the Medical Affairs leadership for Pharmacovigilance for BD’s drug and drug & device combination products, a multi-billion $ segment of BD spread out across several business units. Lead the team that completed GAP analysis of existing and required PV reporting and governance, identified critical gaps in drug-device combination assessment required to be in compliance with EU-MDR, and immediately instituted Drug Safety Review Board for assessment of reported complaints and initiation of adequate actions. -
Vice President, Medical Affairs, Interventional Segment, Bd InterventionBd Jan 2018 - Feb 2019Franklin Lakes, New Jersey, UsIn addition to responsibilities outlined in VP for MA role below, assigned responsibility for ensuring smooth transition of Medical Affairs during the Bard/Becton Dickinson merger. -
Chairman EmeritusWings, The Washington Medical Technology Angel Network Jul 2012 - Dec 2019
-
Worldwide Corporate Vp, Head Of Medical AffairsCr Bard 2010 - 2017Murray Hill, New Jersey, UsAppointed to build a new Medical Affairs Department from scratch, bringing dedicated focus and expertise to the function. This covered Corporate, all Divisions, wholly-owned subsidiaries and International Business Centres including Bard China, Bard Japan, Australia and New Zealand, EMEA, Central and South America (4 MDs, 24 MA team members total, including 11 associates’ strong Medical Support Services team, providing multiple services to external and internal customers including, but not limited to, covering medical and scientific enquiries for the US and Canada 24/7/365, providing guidance for the correct use of all BARD devices, training (internal) customers on BARD devices and their correct use, and answering unsolicited requests for medical and scientific information. -
President And Chairman, Co-FounderWings, The Washington Medical Technology Angel Network May 2009 - Jun 2010WINGS – The Washington Medical Technology Angel Network facilitates seed and early stage investments for medical technology companies (therapeutic and diagnostic devices, healthcare IT, healthcare delivery models, and unregulated biotechnology development tools), growing the industry through increased deal flow in Washington State. We provide rigorous screening processes and subject matter expertise for members and start-ups, mentorship, and relationship building. We work actively with leading research institutions and other angel groups, enabling technologies that help patients.
-
AdvisorRebmann Research Apr 2009 - Jun 2010Schramberg, Baden-Württemberg, DeREBMANN RESEARCH GmbH&Co KG is Germany’s leading provider of premium healthcare business information, delivering independent data, research and analysis that help business (banks, VCs, healthcare practitioners) and government clients make more informed strategic and operational decisions.Rebmann Research - Health Care Intelligence & Analysis™ -
Founder, PresidentImagine2Bcured 2009 - 2010Created novel device and procedure platform for endoluminal metabolic surgery to treat Type 2 Diabetes Mellitus, together with strong team of experienced, seasoned entrepreneurs and engineers.
-
President, FounderKraemer & Kraemer 2008 - 2010Engaged in a range of projects and initiatives, including a new start-up to treat Type 2 Diabetes Mellitus (T2DM), devising prototypes including tissue-welding technology with a team of serial entrepreneurs and engineers, patent applications, fundraising, due diligence for start-ups and working with medical device companies, incubators and start-ups. Additionally, set up and co-led WINGS, the highly effective and innovative trade association serving the life sciences industry.
-
Founder, Chief Medical Officer, Vp For Medical Affairs & Procedure DevelopmentEndogastric Solutions 2003 - 2009Redmond, Wa, UsFounded and grew the business from concept through to fully operational, with a 140-strong team. Latterly, Chief Science & Technology Officer. -
Scientist In ResidenceScout Medical Technologies 2001 - 2003In 2001 Dr. Kraemer moved permanently to Seattle, WA, where he joined Scout Medical Technologies, an incubator for medical devices. In 2003 he and the Scout partners founded EsophyX Inc., now EndoGastric Solutions Inc.. Dr. Kraemer provided medical expertise to Scout, supported Scout portfolio companies with medical advice, and supported the team's due diligence on a number of projects, which were presented to the incubator.
-
Vice President For Community, Medical Content & PrBioropa Gmbh 2000 - 2001B2B e-commerce exchange for the life science industry.
-
SurgeonTechnical University Of Munich 1986 - 2000Munich, Bavaria, De
Stefan J.M. Kraemer, M.D., M.B.A. Skills
Stefan J.M. Kraemer, M.D., M.B.A. Education Details
-
Technical University Of MunichChirurgische Klinik Und Poliklinik Am Klinikum Rechts Der Isar -
Technical University Of MunichMedical School -
Uw Foster School Of BusinessGeneral
Frequently Asked Questions about Stefan J.M. Kraemer, M.D., M.B.A.
What company does Stefan J.M. Kraemer, M.D., M.B.A. work for?
Stefan J.M. Kraemer, M.D., M.B.A. works for Creative Destruction Lab
What is Stefan J.M. Kraemer, M.D., M.B.A.'s role at the current company?
Stefan J.M. Kraemer, M.D., M.B.A.'s current role is Business Associate.
What is Stefan J.M. Kraemer, M.D., M.B.A.'s email address?
Stefan J.M. Kraemer, M.D., M.B.A.'s email address is st****@****vate.ie
What is Stefan J.M. Kraemer, M.D., M.B.A.'s direct phone number?
Stefan J.M. Kraemer, M.D., M.B.A.'s direct phone number is (425) 307*****
What schools did Stefan J.M. Kraemer, M.D., M.B.A. attend?
Stefan J.M. Kraemer, M.D., M.B.A. attended Technical University Of Munich, Technical University Of Munich, Uw Foster School Of Business.
What are some of Stefan J.M. Kraemer, M.D., M.B.A.'s interests?
Stefan J.M. Kraemer, M.D., M.B.A. has interest in Notes, Non Profits Using Innovation, Pulmonary, Disruptive Technologies, Leading, Other Areas Such As Abdominal, Particularly Medical Technology, Endoluminal Surgical Procedures, Æsthetics, More.
What skills is Stefan J.M. Kraemer, M.D., M.B.A. known for?
Stefan J.M. Kraemer, M.D., M.B.A. has skills like Medical Devices, Start Ups, Biotechnology, Healthcare, Fda, Strategy, Surgery, Product Launch, Clinical Research, Pharmaceutical Industry, Cross Functional Team Leadership, Entrepreneurship.
Free Chrome Extension
Find emails, phones & company data instantly
Aero Online
Your AI prospecting assistant
Select data to include:
0 records × $0.02 per record
Download 750 million emails and 100 million phone numbers
Access emails and phone numbers of over 750 million business users. Instantly download verified profiles using 20+ filters, including location, job title, company, function, and industry.
Start your free trial